Vical Reports Positive Swine Flu Vaccine Results

Vical Inc. (Nasdaq: VICL) reported positive results that its swine flu vaccine works in mice. Shares of the biopharmaceutical leaped 50 cents to close at $2.70.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.